Yongyong Lu

Wenzhou, 325000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Retraction: CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis.

Retraction: CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis.

Journal: Bioscience reports

Published: May 06, 2026

Lnc00892 enhances cisplatin sensitivity by inducing apoptosis through the BTAF1/MDM2/STAT5B/XIAP axis in bladder cancer cells.

Lnc00892 enhances cisplatin sensitivity by inducing apoptosis through the BTAF1/MDM2/STAT5B/XIAP axis in bladder cancer cells.

Journal: Biology direct

Published: December 19, 2025

Oncogenic and immunological roles of LAMP5 across cancers and its potential utility in bladder cancer.

Oncogenic and immunological roles of LAMP5 across cancers and its potential utility in bladder cancer.

Journal: Apoptosis : an international journal on programmed cell death

Published: October 14, 2025

Hyaluronic acid-modified doxorubicin-covalent organic framework nanoparticles triggered pyroptosis in combinations with immune checkpoint blockade for the treatment of breast cancer.

Hyaluronic acid-modified doxorubicin-covalent organic framework nanoparticles triggered pyroptosis in combinations with immune checkpoint blockade for the treatment of breast cancer.

Journal: International journal of biological macromolecules

Published: February 19, 2025

A-to-I RNA edited POLA2 attains carcinogenesis in prostatic cancer by impeding immune infiltration and upregulating BTBD7.

A-to-I RNA edited POLA2 attains carcinogenesis in prostatic cancer by impeding immune infiltration and upregulating BTBD7.

Journal: Discover oncology

Published: January 17, 2025

Global trends and projections of occupational trichloroethylene (TCE) exposure-associated kidney cancer: Insights of the Global Burden of Disease (GBD) Study 2021 from 1990 to 2021 and prediction to 2050.

Global trends and projections of occupational trichloroethylene (TCE) exposure-associated kidney cancer: Insights of the Global Burden of Disease (GBD) Study 2021 from 1990 to 2021 and prediction to 2050.

Journal: Ecotoxicology and environmental safety

Published: August 23, 2024

PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy.

PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy.

Journal: Materials today. Bio

Published: August 15, 2024

XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1.

XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1.

Journal: Cell death & disease

Published: June 06, 2024

The quantity, function and anti-tumor effect of Mucosal associated invariant T cells in patients with bladder cancer.

The quantity, function and anti-tumor effect of Mucosal associated invariant T cells in patients with bladder cancer.

Journal: International immunopharmacology

Published: December 20, 2023

Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.

Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.

Journal: Functional & integrative genomics

Published: March 08, 2023

SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein.

SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein.

Journal: Cancer cell international

Published: December 16, 2022

LncRNA BRCAT54 is downregulated and inhibits cancer cell proliferation by downregulating miR-130b-3p through methylation in prostate cancer.

LncRNA BRCAT54 is downregulated and inhibits cancer cell proliferation by downregulating miR-130b-3p through methylation in prostate cancer.

Journal: Journal of biochemical and molecular toxicology

Published: June 02, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026